TrialBMC ophthalmology2012

A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension.

David Eveleth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.